- Home
- VINP vs IRMD Comparison
VINP vs IRMD Comparison
Compare VINP & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VINP
- IRMD
- Stock Information
- Founded
- VINP 2009
- IRMD 1992
- Country
- VINP Brazil
- IRMD United States
- Employees
- VINP N/A
- IRMD N/A
- Industry
- VINP Investment Managers
- IRMD Medical/Dental Instruments
- Sector
- VINP Finance
- IRMD Health Care
- Exchange
- VINP Nasdaq
- IRMD Nasdaq
- Market Cap
- VINP 593.2M
- IRMD 756.5M
- IPO Year
- VINP 2021
- IRMD 2014
- Fundamental
- Price
- VINP $9.79
- IRMD $60.74
- Analyst Decision
- VINP Strong Buy
- IRMD Strong Buy
- Analyst Count
- VINP 2
- IRMD 1
- Target Price
- VINP $13.25
- IRMD $72.00
- AVG Volume (30 Days)
- VINP 51.2K
- IRMD 60.9K
- Earning Date
- VINP 08-06-2025
- IRMD 07-31-2025
- Dividend Yield
- VINP 6.66%
- IRMD 1.14%
- EPS Growth
- VINP N/A
- IRMD 10.72
- EPS
- VINP 0.38
- IRMD 1.55
- Revenue
- VINP $126,696,258.00
- IRMD $75,154,639.00
- Revenue This Year
- VINP $70.28
- IRMD $10.62
- Revenue Next Year
- VINP $14.37
- IRMD $9.69
- P/E Ratio
- VINP $25.64
- IRMD $38.58
- Revenue Growth
- VINP 57.51
- IRMD 11.04
- 52 Week Low
- VINP $8.66
- IRMD $42.34
- 52 Week High
- VINP $11.62
- IRMD $63.29
- Technical
- Relative Strength Index (RSI)
- VINP 53.22
- IRMD 58.74
- Support Level
- VINP $9.43
- IRMD $59.50
- Resistance Level
- VINP $9.70
- IRMD $60.90
- Average True Range (ATR)
- VINP 0.23
- IRMD 1.41
- MACD
- VINP 0.02
- IRMD -0.14
- Stochastic Oscillator
- VINP 62.50
- IRMD 69.91
About VINP Vinci Partners Investments Ltd.
Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.